中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2013年
11期
4816-4819
,共4页
耿会娟%王雅杰%伊正君%康熙雄
耿會娟%王雅傑%伊正君%康熙雄
경회연%왕아걸%이정군%강희웅
多发性硬化%基质金属蛋白酶9%金属蛋白酶1组织抑制剂
多髮性硬化%基質金屬蛋白酶9%金屬蛋白酶1組織抑製劑
다발성경화%기질금속단백매9%금속단백매1조직억제제
Multiple sclerosis%Matrix metalloproteinase 9%Tissue inhibitor of metalloproteinase-1
目的探讨血清和脑脊液中基质金属蛋白酶( MMP)-9及其抑制剂金属蛋白酶组织抑制剂( TIMP)-1与多发性硬化发病及疾病活动的相关性。方法本实验共分四组:多发性硬化组、神经系统炎性疾病(OIND)组、神经系统非炎性疾病(NIND)组和健康人群组。采用酶联免疫吸附试验(ELISA)检测血清MMP-9、血清和脑脊液中TIMP-1的表达水平;采用酶谱法检测脑脊液中MMP-9水平;以MRI检查为多发性硬化疾病活动性判断标准,分析比较多发性硬化活动组和非活动组MMP-9及TIMP-1水平。结果多发性硬化组血清MMP-9水平显著高于NIND组( P<0.05)和健康人群组( P<0.001),血清TIMP-1水平显著低于OIND组( P<0.001)、NIND组( P<0.001)和健康人群组( P<0.001);多发性硬化组脑脊液中MMP-9水平高于NIND组( P<0.05),脑脊液中TIMP-1水平显著低于OIND组( P<0.05);多发性硬化活动期患者血清MMP-9水平、MMP-9/TIMP-1比值分别显著高于非活动期( P均<0.05),活动期血清TIMP-1水平与非活动期无统计学差异。结论检测血清和脑脊液中MMP-9及TIMP-1水平对多发性硬化疾病活动性的监测有一定参考价值。
目的探討血清和腦脊液中基質金屬蛋白酶( MMP)-9及其抑製劑金屬蛋白酶組織抑製劑( TIMP)-1與多髮性硬化髮病及疾病活動的相關性。方法本實驗共分四組:多髮性硬化組、神經繫統炎性疾病(OIND)組、神經繫統非炎性疾病(NIND)組和健康人群組。採用酶聯免疫吸附試驗(ELISA)檢測血清MMP-9、血清和腦脊液中TIMP-1的錶達水平;採用酶譜法檢測腦脊液中MMP-9水平;以MRI檢查為多髮性硬化疾病活動性判斷標準,分析比較多髮性硬化活動組和非活動組MMP-9及TIMP-1水平。結果多髮性硬化組血清MMP-9水平顯著高于NIND組( P<0.05)和健康人群組( P<0.001),血清TIMP-1水平顯著低于OIND組( P<0.001)、NIND組( P<0.001)和健康人群組( P<0.001);多髮性硬化組腦脊液中MMP-9水平高于NIND組( P<0.05),腦脊液中TIMP-1水平顯著低于OIND組( P<0.05);多髮性硬化活動期患者血清MMP-9水平、MMP-9/TIMP-1比值分彆顯著高于非活動期( P均<0.05),活動期血清TIMP-1水平與非活動期無統計學差異。結論檢測血清和腦脊液中MMP-9及TIMP-1水平對多髮性硬化疾病活動性的鑑測有一定參攷價值。
목적탐토혈청화뇌척액중기질금속단백매( MMP)-9급기억제제금속단백매조직억제제( TIMP)-1여다발성경화발병급질병활동적상관성。방법본실험공분사조:다발성경화조、신경계통염성질병(OIND)조、신경계통비염성질병(NIND)조화건강인군조。채용매련면역흡부시험(ELISA)검측혈청MMP-9、혈청화뇌척액중TIMP-1적표체수평;채용매보법검측뇌척액중MMP-9수평;이MRI검사위다발성경화질병활동성판단표준,분석비교다발성경화활동조화비활동조MMP-9급TIMP-1수평。결과다발성경화조혈청MMP-9수평현저고우NIND조( P<0.05)화건강인군조( P<0.001),혈청TIMP-1수평현저저우OIND조( P<0.001)、NIND조( P<0.001)화건강인군조( P<0.001);다발성경화조뇌척액중MMP-9수평고우NIND조( P<0.05),뇌척액중TIMP-1수평현저저우OIND조( P<0.05);다발성경화활동기환자혈청MMP-9수평、MMP-9/TIMP-1비치분별현저고우비활동기( P균<0.05),활동기혈청TIMP-1수평여비활동기무통계학차이。결론검측혈청화뇌척액중MMP-9급TIMP-1수평대다발성경화질병활동성적감측유일정삼고개치。
Objective To assess serum and cerebrospinal fluid ( CSF ) levels of matrix metalloproteinase-9 (MMP-9)and tissue inhibitors of metalloproteinase (TIMP)-1 of multiple sclerosis(MS)patients,and explore the association with disease active stage .Methods Four groups of subjects were tested:MS, other inflammatory neurological disorders(OIND),non-inflammatory neurological disorders(NIND)and health control(HC).MMP-9 of serum and TIMP-1of serum and CSF were measured by enzyme linked immunosorbent assay ( ELISA);The levels of MMP-9 of CSF were measured by gelatin-substrate zymography .Results Serum MMP-9 concentrations were higher in MS than in NIND and in HC(P<0.05,<0.001,respectively),Serum TIMP-1 concentrations were lower in MS than in NIND,in OIND and in HC(P<0.001,<0.001,<0.001,respectively).CSF mean levels of MMP-9 were more elevated in MS than in NIND ( P<0.05 ) , CSF mean levels of TIMP-1 were lower in MS than in OIND ( P<0.05 ) .Serum MMP-9 and MMP-9/TIMP-1 ratio mean levels were increased in MS patients with MRI disease activity compared to patients with non-active disease ( P <0.05 , <0.05 , respectively ) .The differences of serum mean concentrations of TIMP-1 between MS patients with MRI disease activity and patients with non-active disease did not reach statistical significance .Conclusion To investigate serum and CSF levels of MMP-9 and TIMP-1 is valuable in assessing disease activity of MS .